nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—SHMT1—prostate gland—prostate cancer	0.0252	0.102	CbGeAlD
Mimosine—CCL2—prostate gland—prostate cancer	0.0234	0.0944	CbGeAlD
Mimosine—SHMT1—seminal vesicle—prostate cancer	0.0213	0.0862	CbGeAlD
Mimosine—CCL2—seminal vesicle—prostate cancer	0.0198	0.0799	CbGeAlD
Mimosine—SHMT1—renal system—prostate cancer	0.0172	0.0695	CbGeAlD
Mimosine—CCL2—epithelium—prostate cancer	0.0172	0.0694	CbGeAlD
Mimosine—SHMT1—urethra—prostate cancer	0.0169	0.0682	CbGeAlD
Mimosine—CCL2—renal system—prostate cancer	0.0159	0.0644	CbGeAlD
Mimosine—CCL2—urethra—prostate cancer	0.0157	0.0632	CbGeAlD
Mimosine—SHMT1—bone marrow—prostate cancer	0.013	0.0525	CbGeAlD
Mimosine—TYR—lymph node—prostate cancer	0.013	0.0525	CbGeAlD
Mimosine—CCL2—bone marrow—prostate cancer	0.0121	0.0487	CbGeAlD
Mimosine—SHMT1—testis—prostate cancer	0.0111	0.0449	CbGeAlD
Mimosine—CCL2—testis—prostate cancer	0.0103	0.0416	CbGeAlD
Mimosine—L-Tyrosine—TH—prostate cancer	0.00943	1	CrCbGaD
Mimosine—SHMT1—Podofilox—Etoposide—prostate cancer	0.00833	0.424	CbGdCrCtD
Mimosine—SHMT1—lymph node—prostate cancer	0.00806	0.0325	CbGeAlD
Mimosine—CCL2—lymph node—prostate cancer	0.00747	0.0302	CbGeAlD
Mimosine—CCL2—Methylprednisolone—Prednisone—prostate cancer	0.00194	0.0986	CbGdCrCtD
Mimosine—CCL2—Amcinonide—Prednisone—prostate cancer	0.00154	0.0782	CbGdCrCtD
Mimosine—CCL2—Fluorometholone—Prednisone—prostate cancer	0.0012	0.0611	CbGdCrCtD
Mimosine—CCL2—Clobetasol propionate—Prednisone—prostate cancer	0.00102	0.0517	CbGdCrCtD
Mimosine—CCL2—Flunisolide—Prednisone—prostate cancer	0.001	0.051	CbGdCrCtD
Mimosine—CCL2—Triamcinolone—Prednisone—prostate cancer	0.000993	0.0505	CbGdCrCtD
Mimosine—CCL2—Desoximetasone—Prednisone—prostate cancer	0.000943	0.048	CbGdCrCtD
Mimosine—CCL2—Diflorasone—Prednisone—prostate cancer	0.000915	0.0465	CbGdCrCtD
Mimosine—CCL2—Budesonide—Prednisone—prostate cancer	0.000802	0.0408	CbGdCrCtD
Mimosine—CCL2—Dexamethasone—Prednisone—prostate cancer	0.000491	0.025	CbGdCrCtD
Mimosine—CCL2—Betamethasone—Prednisone—prostate cancer	0.000491	0.025	CbGdCrCtD
Mimosine—CCL2—Metabolism of proteins—CALR—prostate cancer	0.000298	0.000412	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CX3CL1—prostate cancer	0.000297	0.000411	CbGpPWpGaD
Mimosine—SHMT1—Disease—HIST1H2BG—prostate cancer	0.000297	0.000411	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TP53—prostate cancer	0.000293	0.000405	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TBXAS1—prostate cancer	0.00029	0.000401	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTA4—prostate cancer	0.00029	0.000401	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL17RD—prostate cancer	0.00029	0.000401	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PDE4D—prostate cancer	0.000289	0.0004	CbGpPWpGaD
Mimosine—SHMT1—Disease—NPPA—prostate cancer	0.000287	0.000397	CbGpPWpGaD
Mimosine—SHMT1—Disease—HIST1H4H—prostate cancer	0.000287	0.000397	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ACE—prostate cancer	0.000284	0.000392	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTA2—prostate cancer	0.000283	0.000391	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCG5—prostate cancer	0.000279	0.000386	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SULT1A1—prostate cancer	0.000279	0.000386	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GNG5—prostate cancer	0.000275	0.00038	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTA1—prostate cancer	0.000273	0.000377	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTO1—prostate cancer	0.00027	0.000373	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HSD3B2—prostate cancer	0.00027	0.000373	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NAT2—prostate cancer	0.00027	0.000373	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL6—prostate cancer	0.000268	0.00037	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LRP2—prostate cancer	0.000258	0.000357	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PLCB2—prostate cancer	0.000258	0.000357	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP2C18—prostate cancer	0.000258	0.000357	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JUP—prostate cancer	0.000258	0.000357	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—WNT4—prostate cancer	0.000258	0.000357	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—PLAUR—prostate cancer	0.000255	0.000352	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—P4HB—prostate cancer	0.000253	0.00035	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC22A1—prostate cancer	0.000247	0.000341	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RALBP1—prostate cancer	0.000246	0.000341	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MC2R—prostate cancer	0.000246	0.000341	CbGpPWpGaD
Mimosine—SHMT1—Disease—B2M—prostate cancer	0.000244	0.000337	CbGpPWpGaD
Mimosine—SHMT1—Disease—TGFBR1—prostate cancer	0.000244	0.000337	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SULT2A1—prostate cancer	0.00024	0.000332	CbGpPWpGaD
Mimosine—SHMT1—Disease—RPS19—prostate cancer	0.00024	0.000332	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKR1C3—prostate cancer	0.00024	0.000332	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTHLH—prostate cancer	0.00024	0.000331	CbGpPWpGaD
Mimosine—SHMT1—Disease—PRKACB—prostate cancer	0.000239	0.00033	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MED12—prostate cancer	0.000236	0.000327	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GNG5—prostate cancer	0.000235	0.000324	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PRKACB—prostate cancer	0.000234	0.000324	CbGpPWpGaD
Mimosine—SHMT1—Disease—PPP3CA—prostate cancer	0.000233	0.000322	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PPP3CA—prostate cancer	0.000229	0.000316	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NCOA3—prostate cancer	0.000226	0.000312	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ANXA1—prostate cancer	0.000225	0.000311	CbGpPWpGaD
Mimosine—SHMT1—Disease—PRKCZ—prostate cancer	0.000225	0.000311	CbGpPWpGaD
Mimosine—SHMT1—Disease—CALR—prostate cancer	0.000221	0.000306	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PENK—prostate cancer	0.00022	0.000304	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000218	0.000302	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGFR4—prostate cancer	0.000217	0.000301	CbGpPWpGaD
Mimosine—SHMT1—Disease—PARP1—prostate cancer	0.000217	0.000301	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HPGDS—prostate cancer	0.000216	0.000298	CbGpPWpGaD
Mimosine—SHMT1—Disease—CALCA—prostate cancer	0.000215	0.000297	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP2C19—prostate cancer	0.000214	0.000296	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CALCA—prostate cancer	0.000211	0.000292	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GHR—prostate cancer	0.00021	0.00029	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTT1—prostate cancer	0.000209	0.000289	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ACHE—prostate cancer	0.000209	0.000289	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP2A6—prostate cancer	0.000207	0.000286	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL12—prostate cancer	0.000206	0.000285	CbGpPWpGaD
Mimosine—SHMT1—Disease—HSPA1A—prostate cancer	0.000206	0.000285	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKR1C3—prostate cancer	0.000201	0.000278	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NRP1—prostate cancer	0.000201	0.000278	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PRKACB—prostate cancer	0.0002	0.000276	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP17A1—prostate cancer	0.000198	0.000274	CbGpPWpGaD
Mimosine—SHMT1—Disease—CASP9—prostate cancer	0.000198	0.000273	CbGpPWpGaD
Mimosine—SHMT1—Disease—PRKCQ—prostate cancer	0.000191	0.000265	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NCOA2—prostate cancer	0.000189	0.000261	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PRKCQ—prostate cancer	0.000188	0.00026	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VIP—prostate cancer	0.000187	0.000258	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GNRH1—prostate cancer	0.000187	0.000258	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGF10—prostate cancer	0.000182	0.000251	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LPAR1—prostate cancer	0.000181	0.00025	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRP—prostate cancer	0.000181	0.00025	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC5A5—prostate cancer	0.00018	0.000249	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LRP2—prostate cancer	0.000179	0.000248	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PLCB2—prostate cancer	0.000179	0.000248	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ADRB2—prostate cancer	0.000177	0.000244	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—LEP—prostate cancer	0.000176	0.000243	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP2E1—prostate cancer	0.000176	0.000243	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—P4HB—prostate cancer	0.000176	0.000243	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CX3CL1—prostate cancer	0.000176	0.000243	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NQO1—prostate cancer	0.000174	0.00024	CbGpPWpGaD
Mimosine—SHMT1—Disease—TGFBR2—prostate cancer	0.000173	0.000239	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—VAV3—prostate cancer	0.000172	0.000238	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HIST1H2BG—prostate cancer	0.000172	0.000238	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TH—prostate cancer	0.000171	0.000237	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GRB7—prostate cancer	0.000171	0.000236	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDE4D—prostate cancer	0.000171	0.000236	CbGpPWpGaD
Mimosine—SHMT1—Disease—ITPR1—prostate cancer	0.00017	0.000235	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP3A4—prostate cancer	0.000169	0.000234	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ITPR1—prostate cancer	0.000167	0.000231	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP1B1—prostate cancer	0.000167	0.00023	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HIST1H4H—prostate cancer	0.000166	0.00023	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCL8—prostate cancer	0.000166	0.00023	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GNG5—prostate cancer	0.000162	0.000225	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GGT1—prostate cancer	0.000161	0.000223	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NCOA1—prostate cancer	0.000159	0.00022	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP19A1—prostate cancer	0.000157	0.000216	CbGpPWpGaD
Mimosine—SHMT1—Disease—LPL—prostate cancer	0.000156	0.000216	CbGpPWpGaD
Mimosine—SHMT1—Disease—PDGFRB—prostate cancer	0.000155	0.000214	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—RXRA—prostate cancer	0.000151	0.000209	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—INS—prostate cancer	0.00015	0.000208	CbGpPWpGaD
Mimosine—SHMT1—Disease—ERCC2—prostate cancer	0.000149	0.000207	CbGpPWpGaD
Mimosine—SHMT1—Disease—ERBB3—prostate cancer	0.000146	0.000202	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGFR2—prostate cancer	0.000146	0.000202	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—COMT—prostate cancer	0.000146	0.000201	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—IGF1—prostate cancer	0.000146	0.000201	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTP1—prostate cancer	0.000145	0.0002	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ITPR1—prostate cancer	0.000143	0.000197	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTHLH—prostate cancer	0.000142	0.000196	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TGFBR1—prostate cancer	0.000142	0.000196	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—MMP2—prostate cancer	0.000141	0.000195	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTHFR—prostate cancer	0.000141	0.000194	CbGpPWpGaD
Mimosine—SHMT1—Disease—TERT—prostate cancer	0.00014	0.000194	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKR1C3—prostate cancer	0.000139	0.000193	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRKACB—prostate cancer	0.000139	0.000192	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—THBS1—prostate cancer	0.000135	0.000187	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PPP3CA—prostate cancer	0.000135	0.000187	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TYMS—prostate cancer	0.000135	0.000186	CbGpPWpGaD
Mimosine—SHMT1—Disease—HIF1A—prostate cancer	0.000134	0.000185	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTM1—prostate cancer	0.000133	0.000184	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ANXA1—prostate cancer	0.000133	0.000184	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LPL—prostate cancer	0.000131	0.000181	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRKCZ—prostate cancer	0.000131	0.000181	CbGpPWpGaD
Mimosine—SHMT1—Disease—CAV1—prostate cancer	0.00013	0.000179	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP1A1—prostate cancer	0.000126	0.000175	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGFR4—prostate cancer	0.000126	0.000174	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PARP1—prostate cancer	0.000126	0.000174	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ERCC2—prostate cancer	0.000125	0.000173	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CALCA—prostate cancer	0.000125	0.000172	CbGpPWpGaD
Mimosine—SHMT1—Disease—BAD—prostate cancer	0.000122	0.000169	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCL12—prostate cancer	0.000122	0.000168	CbGpPWpGaD
Mimosine—SHMT1—Disease—APC—prostate cancer	0.000118	0.000163	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MTHFR—prostate cancer	0.000118	0.000163	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—CXCL8—prostate cancer	0.000117	0.000162	CbGpPWpGaD
Mimosine—SHMT1—Disease—EGF—prostate cancer	0.000117	0.000161	CbGpPWpGaD
Mimosine—SHMT1—Disease—IRS1—prostate cancer	0.000117	0.000161	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CG—prostate cancer	0.000116	0.00016	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPARA—prostate cancer	0.000115	0.00016	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CASP9—prostate cancer	0.000115	0.000158	CbGpPWpGaD
Mimosine—SHMT1—Disease—GSK3B—prostate cancer	0.000113	0.000157	CbGpPWpGaD
Mimosine—SHMT1—Disease—INS—prostate cancer	0.000112	0.000154	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRKCQ—prostate cancer	0.000111	0.000154	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NGFR—prostate cancer	0.000111	0.000154	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAP3K7—prostate cancer	0.00011	0.000152	CbGpPWpGaD
Mimosine—SHMT1—Disease—CREBBP—prostate cancer	0.000109	0.000151	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CAV1—prostate cancer	0.000109	0.00015	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—CTNNB1—prostate cancer	0.000108	0.000149	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGF10—prostate cancer	0.000106	0.000146	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAP2K1—prostate cancer	0.000104	0.000144	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADRB2—prostate cancer	0.000104	0.000144	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CD—prostate cancer	0.000104	0.000143	CbGpPWpGaD
Mimosine—SHMT1—Disease—SERPINE1—prostate cancer	0.000103	0.000142	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAP2K1—prostate cancer	0.000103	0.000142	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CD—prostate cancer	0.000102	0.000141	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VAV3—prostate cancer	0.000102	0.000141	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TGFBR2—prostate cancer	0.0001	0.000139	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGF2—prostate cancer	9.94e-05	0.000137	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CG—prostate cancer	9.89e-05	0.000137	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ITPR1—prostate cancer	9.88e-05	0.000137	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOS3—prostate cancer	9.8e-05	0.000135	CbGpPWpGaD
Mimosine—SHMT1—Disease—JAK2—prostate cancer	9.52e-05	0.000132	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IGF1R—prostate cancer	9.44e-05	0.000131	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—INS—prostate cancer	9.36e-05	0.000129	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—JAK2—prostate cancer	9.35e-05	0.000129	CbGpPWpGaD
Mimosine—SHMT1—Disease—MDM2—prostate cancer	9.3e-05	0.000129	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CREBBP—prostate cancer	9.17e-05	0.000127	CbGpPWpGaD
Mimosine—SHMT1—Disease—ERBB2—prostate cancer	9.17e-05	0.000127	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LPL—prostate cancer	9.05e-05	0.000125	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CB—prostate cancer	9.05e-05	0.000125	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDGFRB—prostate cancer	8.97e-05	0.000124	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTGS2—prostate cancer	8.96e-05	0.000124	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CB—prostate cancer	8.88e-05	0.000123	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ITGB3—prostate cancer	8.75e-05	0.000121	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CD—prostate cancer	8.69e-05	0.00012	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL8—prostate cancer	8.54e-05	0.000118	CbGpPWpGaD
Mimosine—SHMT1—Disease—CDKN1B—prostate cancer	8.49e-05	0.000117	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ERBB3—prostate cancer	8.48e-05	0.000117	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGFR2—prostate cancer	8.47e-05	0.000117	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NOS3—prostate cancer	8.21e-05	0.000113	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL2—prostate cancer	8.16e-05	0.000113	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TERT—prostate cancer	8.13e-05	0.000112	CbGpPWpGaD
Mimosine—SHMT1—Disease—CTNNB1—prostate cancer	8.02e-05	0.000111	CbGpPWpGaD
Mimosine—SHMT1—Disease—CDKN1A—prostate cancer	7.83e-05	0.000108	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTEN—prostate cancer	7.82e-05	0.000108	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HIF1A—prostate cancer	7.78e-05	0.000107	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LEP—prostate cancer	7.59e-05	0.000105	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CB—prostate cancer	7.58e-05	0.000105	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CAV1—prostate cancer	7.52e-05	0.000104	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTGS2—prostate cancer	7.51e-05	0.000104	CbGpPWpGaD
Mimosine—SHMT1—Disease—EP300—prostate cancer	7.45e-05	0.000103	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KDR—prostate cancer	7.44e-05	0.000103	CbGpPWpGaD
Mimosine—SHMT1—Disease—SRC—prostate cancer	7.25e-05	0.0001	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ESR1—prostate cancer	7.25e-05	0.0001	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BAD—prostate cancer	7.07e-05	9.78e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—STAT3—prostate cancer	6.99e-05	9.67e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CG—prostate cancer	6.85e-05	9.47e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APC—prostate cancer	6.85e-05	9.47e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IRS1—prostate cancer	6.77e-05	9.36e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EGF—prostate cancer	6.77e-05	9.36e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GSK3B—prostate cancer	6.57e-05	9.09e-05	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTEN—prostate cancer	6.55e-05	9.05e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—MYC—prostate cancer	6.5e-05	8.98e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—INS—prostate cancer	6.48e-05	8.96e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—TGFB1—prostate cancer	6.48e-05	8.96e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—EGFR—prostate cancer	6.35e-05	8.78e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CREBBP—prostate cancer	6.35e-05	8.78e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IGF1—prostate cancer	6.27e-05	8.67e-05	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—EP300—prostate cancer	6.24e-05	8.63e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—EGFR—prostate cancer	6.24e-05	8.63e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAP2K1—prostate cancer	6.06e-05	8.38e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CD—prostate cancer	6.02e-05	8.33e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—KRAS—prostate cancer	6e-05	8.3e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SERPINE1—prostate cancer	5.96e-05	8.23e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—KRAS—prostate cancer	5.9e-05	8.15e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGF2—prostate cancer	5.77e-05	7.97e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NOS3—prostate cancer	5.69e-05	7.86e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JAK2—prostate cancer	5.53e-05	7.64e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CA—prostate cancer	5.51e-05	7.62e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CA—prostate cancer	5.42e-05	7.49e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MDM2—prostate cancer	5.39e-05	7.46e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ERBB2—prostate cancer	5.32e-05	7.35e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CB—prostate cancer	5.25e-05	7.26e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCL8—prostate cancer	5.04e-05	6.97e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CDKN1B—prostate cancer	4.93e-05	6.81e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6—prostate cancer	4.88e-05	6.75e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CASP3—prostate cancer	4.83e-05	6.67e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL2—prostate cancer	4.82e-05	6.66e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6—prostate cancer	4.8e-05	6.63e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCND1—prostate cancer	4.7e-05	6.5e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CTNNB1—prostate cancer	4.65e-05	6.43e-05	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CA—prostate cancer	4.62e-05	6.38e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MMP9—prostate cancer	4.56e-05	6.31e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CDKN1A—prostate cancer	4.55e-05	6.28e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTEN—prostate cancer	4.54e-05	6.27e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—prostate cancer	4.5e-05	6.23e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—prostate cancer	4.42e-05	6.12e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EP300—prostate cancer	4.33e-05	5.98e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SRC—prostate cancer	4.21e-05	5.82e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VEGFA—prostate cancer	4.1e-05	5.66e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT3—prostate cancer	4.06e-05	5.61e-05	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—prostate cancer	3.77e-05	5.22e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MYC—prostate cancer	3.77e-05	5.21e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TGFB1—prostate cancer	3.76e-05	5.2e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EGFR—prostate cancer	3.69e-05	5.1e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KRAS—prostate cancer	3.48e-05	4.82e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CA—prostate cancer	3.2e-05	4.42e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TP53—prostate cancer	3.1e-05	4.28e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6—prostate cancer	2.83e-05	3.92e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—prostate cancer	2.61e-05	3.61e-05	CbGpPWpGaD
